Search Results - "Foshag, Leland"

Analysis of 10-year trends in Medicare Physician Fee Schedule payments in surgery by Sibia, Udai S., Millen, Janelle-Cheri, Klune, John R., Bilchik, Anton, Foshag, Leland J.

“…Medicare expenditures have steadily increased over the decades, and yet Medicare Physician Fee Schedule payments for individual services have declined. We…”
Get full text

A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients by Ono, Shigeshi, Oyama, Takashi, Lam, Stella, Chong, Kelly, Foshag, Leland J, Hoon, Dave S B

“…Circulating cell-free(cf) microRNAs (miRNAs) have been reported to exist in plasma. MicroRNA-210(miR-210) is known to play important roles in the tumor hypoxic…”
Get full text

Association of Surgical Treatment, Systemic Therapy, and Survival in Patients With Abdominal Visceral Melanoma Metastases, 1965-2014: Relevance of Surgical Cure in the Era of Modern Systemic Therapy by Deutsch, Gary B, Flaherty, Devin C, Kirchoff, Daniel D, Bailey, Mariel, Vitug, Sarah, Foshag, Leland J, Faries, Mark B, Bilchik, Anton J

“…Systemic therapy for metastatic melanoma has evolved rapidly during the last decade, and patient treatment has become more complex. To evaluate the survival…”
Get more information

Does Residual Invasive Disease in Wide Local Excision after Diagnosis with Partial Biopsy Technique Influence Survival in Melanoma? Matched-Pair Analysis of Multicenter Selective Lymphadenectomy Trial I and II by Ramiscal, Judi Anne B, Stern, Stacey L, Wilson, Ana K, Lorimer, Patrick D, Lee, Nathaniel A, Goldfarb, Melanie R, Foshag, Leland J, Fischer, Trevan D

“…Current guidelines recommend excisional/complete biopsy for melanoma diagnosis, owing to high rates of residual disease found at wide local excision (WLE)…”
Get full text

Mycobacterium bovis Bacillus Calmette-Guérin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function by Lardone, Ricardo D, Chan, Alfred A, Lee, Agnes F, Foshag, Leland J, Faries, Mark B, Sieling, Peter A, Lee, Delphine J

“…Intralesional bacillus Calmette-Guérin (BCG) has long been a relatively inexpensive therapy for inoperable cutaneous metastatic melanoma (CMM), although…”
Get full text

Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial Immunotherapy by Lin, Selena Y, Chang, Shu-Ching, Lam, Stella, Ramos, Romela Irene, Tran, Kevin, Ohe, Shuichi, Salomon, Matthew P, Bhagat, Ali Asgar S, Lim, Chwee Teck, Fischer, Trevan D, Foshag, Leland J, Boley, Christine L, O'Day, Steven J, Hoon, Dave S B

“…Blood molecular profiling of circulating tumor cells (CTCs) can enable monitoring of patients with metastatic melanoma during checkpoint inhibitor…”
Get full text

Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma by Lee, David Y., Huynh, Kelly T., Teng, Annabelle, Lau, Briana J., Vitug, Sarah, Lee, Ji-Hey, Stern, Stacey L., Foshag, Leland J., Faries, Mark B.

“…Background The status of the sentinel lymph node in melanoma is an important prognostic factor. The clinical predictors and implications of false-negative (FN)…”
Get full text

Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma by Lee, David Y., MD, Lau, Briana J., MD, Huynh, Kelly T., MD, Flaherty, Devin C., DO, PhD, Lee, Ji-Hey, PhD, Stern, Stacey L., MS, O’ Day, Steve J., MD, Foshag, Leland J., MD, FACS, Faries, Mark B., MD, FACS

“…Background The need for complete lymph node dissection (CLND) in patients with positive sentinel lymph node biopsy (SNB) is an important unanswered clinical…”
Get full text

Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease by Uppal, Abhineet, Stern, Stacey, Thompson, John F., Foshag, Leland, Mizzollo, Nicola, Nieweg, Omgo E., Hoekstra, Harald J., Roses, Daniel F., Sondak, Vernon K., Kashani-Sabet, Mohammed, Coventry, Brendon J., Cochran, Alistair J., Fujita, Manabu, Sim-Shin, Myung, Elashoff, David, Elashoff, Robert M., Faries, Mark B.

“…Background Recommended treatment for patients with sentinel lymph node (SLN)-positive melanoma has recently changed. Randomized trials demonstrated equivalent…”
Get full text

Pediatric-protocol of multimodal therapy is associated with improved survival in AYAs and adults with rhabdomyosarcoma by Fischer, Trevan D., Gaitonde, Shrawan G., Bandera, Bradley C., Raval, Mehul V., Vasudevan, Sanjeev A., Gow, Kenneth W., Beierle, Elizabeth A., Doski, John J., Goldin, Adam B., Langer, Monica, Nuchtern, Jed G., Stern, Stacey, Foshag, Leland J., Goldfarb, Melanie

“…Multimodal therapy is the standard treatment for pediatric rhabdomyosarcoma, but for adolescents and young adults (AYAs: ages 15–39) and older adults with…”
Get full text

Chemokine Receptor CXCR4 Expression in Colorectal Cancer Patients Increases the Risk for Recurrence and for Poor Survival by KIM, Joseph, TAKEUCHI, Hiroya, LAM, Stella T, TURNER, Roderick R, WANG, He-Jing, KUO, Christine, FOSHAG, Leland, BILCHIK, Anton J, HOON, Dave S. B

“…Liver metastasis is the predominant cause of colorectal cancer (CRC) related mortality. Chemokines, soluble factors that orchestrate hematopoetic cell…”
Get full text

Combined Intralesional Bacille Calmette-Guérin (BCG) and Topical Imiquimod for In-transit Melanoma by KIDNER, Travis B, MORTON, Donald L, LEE, Delphine J, HOBAN, Mary, FOSHAG, Leland J, TURNER, Roderick R, FARIES, Mark B

“…The introduction of numerous immunotherapeutic agents into the clinical arena has allowed the long-time promise of immunotherapy to begin to become reality…”
Get full text

Evolving Therapeutic Strategies in Mucosal Melanoma Have Not Improved Survival Over Five Decades by Kirchoff, Daniel D, Deutsch, Gary B, Foshag, Leland J, Lee, Ji Hey, Sim, Myung-Shin, Faries, Mark B

“…Mucosal melanoma represents a distinct minority of disease sites and portends a worse outcome. The ideal treatment and role of adjuvant therapy remains unknown…”
Get more information

Smoking Status and Survival in Patients With Early-Stage Primary Cutaneous Melanoma by Jackson, Katherine M, Jones, Peter C, Fluke, Laura M, Fischer, Trevan D, Thompson, John F, Cochran, Alistair J, Stern, Stacey L, Faries, Mark B, Hoon, Dave S B, Foshag, Leland J

“…While smoking is associated with a decreased incidence of cutaneous melanoma, the association of smoking with melanoma progression and death is not well…”
Get full text

Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned by Bleicher, Richard J, Allegra, David P, Nora, Dean T, Wood, Thomas F, Foshag, Leland J, Bilchik, Anton J

“…Radiofrequency ablation (RFA) is a promising technique for unresectable hepatic malignancies. We reviewed our RFA experience to identify variables affecting…”
Get full text

Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by Mycobacterium bovis Bacille Calmette-Guérin by Yang, Junbao, Jones, Maris S, Ramos, Romela Irene, Chan, Alfred A, Lee, Agnes F, Foshag, Leland J, Sieling, Peter A, Faries, Mark B, Lee, Delphine J

“…bacille Calmette-Guérin (BCG) is listed as an intralesional (IL) therapeutic option for inoperable stage III in-transit melanoma in the National Comprehensive…”
Get full text

Adrenalectomy for Metastatic Melanoma: Current Role in the Age of Nonsurgical Treatments by Flaherty, Devin C, Deutsch, Gary B, Kirchoff, Daniel D, Lee, Jihey, Huynh, Kelly T, Lee, David Y, Foshag, Leland J, Bilchik, Anton J, Faries, Mark B

“…Surgical resection of metastases to the adrenal gland can improve overall survival of patients with stage IV melanoma, but its relative value with respect to…”
Get more information

Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases by Morton, Donald L, Hoon, Dave S B, Cochran, Alistair J, Turner, Roderick R, Essner, Richard, Takeuchi, Hiroya, Wanek, Leslie A, Glass, Edwin, Foshag, Leland J, Hsueh, Eddy C, Bilchik, Anton J, Elashoff, David, Elashoff, Robert

“…Lymphatic mapping and sentinel lymphadenectomy (LM/SL) have been applied to virtually all solid neoplasms since our original description of LM/SL for melanoma…”
Get full text

Prolonged Survival After Complete Resection of Disseminated Melanoma and Active Immunotherapy With a Therapeutic Cancer Vaccine by HSUEH, Eddy C, ESSNER, Richard, FOSHAG, Leland J, OLLILA, David W, GAMMON, Guy, O'DAY, Steven J, BOASBERG, Peter D, STERN, Stacey L, XING YE, MORTON, Donald L

“…The curative effect of surgery in certain patients with metastatic melanoma suggests the presence of endogenous antitumor responses. Because melanoma is…”
Get full text

Role of Sentinel Lymphadenectomy in Thin Invasive Cutaneous Melanomas by BLEICHER, Richard J, ESSNER, Richard, FOSHAG, Leland J, WANEK, Leslie A, MORTON, Donald L

“…Regional lymph node status is the strongest prognostic determinant in early-stage melanoma. Lymphatic mapping and sentinel lymphadenectomy (LM/SL) is standard…”
Get full text